Literature DB >> 8213807

The measurement of dialysis access recirculation.

R A Sherman1.   

Abstract

The measurement of dialysis access recirculation has important diagnostic implications. Recent recognition that its traditional means of measurement is fraught with the potential for substantially overestimating access recirculation requires that we alter current practice. Most of the potential error in the measurement can be overcome by using an arterial rather than a venous specimen for the "systemic" sample. For practical purposes, such a sample can be drawn from the dialysis afferent (arterial) line as long as it is done in a manner that minimizes both contamination by recirculated blood as well as the increase in blood urea nitrogen that occurs when the arteriovenous blood urea nitrogen gradient is dissipated by slowing or stopping dialysis.

Entities:  

Mesh:

Year:  1993        PMID: 8213807     DOI: 10.1016/s0272-6386(12)80940-1

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  4 in total

1.  Reversed connection of cuffed, tunneled, dual-lumen catheters with increased blood flow rate maintains the adequacy of delivered dialysis despite the higher access recirculation.

Authors:  Varvara Kousoula; Panagiotis I Georgianos; Konstantinos Mavromatidis; Christos Syrganis; Elias Thodis; Stylianos Panagoutsos; Ploumis Passadakis
Journal:  Int Urol Nephrol       Date:  2019-08-30       Impact factor: 2.370

2.  Surveillance of hemodialysis vascular access.

Authors:  William L Whittier
Journal:  Semin Intervent Radiol       Date:  2009-06       Impact factor: 1.513

3.  Catheter Port Reversal in Citrate Continuous Veno-Venous Hemofiltration.

Authors:  Willem Boer; Mathias Van Tornout; Margot Vander Laenen; Kim Engelen; Ingrid Meex; Philippe Jorens
Journal:  Kidney Int Rep       Date:  2021-08-13

4.  A review article: access recirculation among end stage renal disease patients undergoing maintenance hemodialysis.

Authors:  Abbasali Zeraati; Seyed Seifollah Beladi Mousavi; Marzieh Beladi Mousavi
Journal:  Nephrourol Mon       Date:  2013-03-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.